Enhancing the value of PCSK9 monoclonal antibodies by identifying patients most likely to benefit. A consensus statement from the National Lipid Association
- Resource Type
- Article
- Source
- In
Journal of Clinical Lipidology July-August 2019 13(4):525-537 - Subject
- Language
- ISSN
- 1933-2874